CEM

Companies CEM

Products CEM

Discover SP-D - Pressurized Microwave Digestion System

CEM's ActiVent vessels are the easiest-to-use vessels available for microwave digestion. Just load your sample and snap on the cap! more

The smallest automated microwave synthesizer commercially available

The Explorer-12 Hybrid combines the best of automation with all of the flexibility associated with the Discover Focused Microwave Synthesis System more

Phönix™ Microwave Muffle Furnace

The new Phoenix line of microwave muffle furnaces offers unmatched versatility and speed in a rugged, easy-to-use system more

Videos CEM

One Touch Makes All the Difference

Totally redesigned with an impressive list of features and capabilities, MARS 6 was developed to make microwave sample preparation virtually effortless. Advances in ICP and ICP-MS systems demand a microwave sample preparation system capable of providing fast, complete digestions for lower detection more

Discover SP-D - Pressurized Microwave Digestion System

Welcome to a revolutionary advance in pressurized microwave digestion! Fast and remarkably simple, the Discover SP-D changes the laboratory paradigm for microwave digestion. Escape the confines of traditional box-style microwave digestion systems and experience an incredible ease-of-use you’ve never more

Phönix™ Microwave Muffle Furnace

The Phönix Muffle Furnaces enable companies in many diverse industries to improve their process control, allowing them to make rapid adjustments to reduce "out-of-specification" product. These systems can perform many high temperature applications up to 97% faster than traditional muffle furnaces. T more

News CEM

• Molecular 'firing squad' in mice triggered by overeating destroys metabolism

  Overeating in mice triggers a molecule once considered to be only involved in detecting and fighting viruses to also destroy normal metabolism, leading to insulin resistance and setting the stage for diabetes. The new study, led by researchers at the Harvard School of Public Health (HSPH), specifica more

• CEM Receives Fourth Patent for Microwave Peptide Synthesis

  CEM announced that its fourth US patent covering microwave-assisted peptide synthesis (US7,582,728) was issued on September 1, 2009. The patent contains broad claims regarding the process of using microwave energy to accelerate two key steps in performing almost all solid phase peptide synthesis, de more

• Urine analysis enables cardiovascular risk assessment

  Coronary artery disease (CAD) is the leading cause of morbidity and mortality worldwide. A vast amount of deaths and disabilities caused by CAD could be cut by an early diagnosis, enabling effective individual actions for preventing clinical events like acute myocardial infarction. Researchers of m more

Publications CEM

• A Novel Manganese Complex, Mn-(II) N-(2-Hydroxy Acetophenone) Glycinate overcomes Multidrug-Resistance in Cancer

  Publication date: Available online 9 May 2013 Source:European Journal of Pharmaceutical Sciences Author(s): Ruma Dey Ghosh , Kaushik Banerjee , Satyajit Das , Avishek Ganguly , Paramita Chakraborty , Avijit Sarkar , Mitali Chatterjee , Soumitra K Choudhuri Multidrug resistance (MDR) re more

• Efficient Delivery of Cell Impermeable Phosphopeptides by a Cyclic Peptide Amphiphile Containing Tryptophan and Arginine

  Phosphopeptides are valuable reagent probes for studying protein–protein and protein–ligand interactions. The cellular delivery of phosphopeptides is challenging because of the presence of the negatively charged phosphate group. The cellular uptake of a number of fluorescent-labeled phosphopeptides, more

• Testing the diathesis‐stress model: 5‐HTTLPR, childhood emotional maltreatment, and vulnerability to social anxiety disorder

  Abstract Regarding the development of social anxiety disorder (SAD), a diathesis‐stress paradigm including biological vulnerabilities and environmental stressors can be assumed. However, studies dealing with the etiology of SAD did not integrate both aspects so far. We examined a particular diat more

Market studies CEM

• Optimer Pharmaceuticals, Inc. (OPTR) - Financial and Strategic SWOT Analysis Review

  Optimer Pharmaceuticals, Inc. (Optimer) is a publicly held US-based biopharmaceutical company. The company is principally engaged in discovering, developing, and commercializing anti-infective products. It primarily focuses on developing products targeting gastrointestinal infections and associated more

Websites CEM